Prevalence of autoimmune diseases has led to an upsurge in demand for plasmapheresis globally. Growing need for conducting an extracorporeal therapy is further expected to impact growth of the global autoimmune diseases market positively. Some of the autoimmune diseases that increasingly fuel demand for plasmapheresis include type 1 diabetes, celiac disease, rheumatoid arthritis, temporal arteritis and lupus. In a recently published report, CDC stated that 9.4% of the population in the U.S. have diabetes, and 30.3 million globally. Plasmapheresis is also used for treatment of various forms of neurotherapy and sickle cell diseases.
According to Fact.MR, the global plasmapheresis market is expected to represent a value of over US$ 1,500 Mn by the end of 2026.
(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)
For more insights, request sample of this report.
Treatment of the Autoimmune Diseases to Boost Demand
Increasing prevalence of various autoimmune diseases will continue to fuel demand for extracorporeal therapies globally. Occurrence of autoimmune disorders such as lupus can significantly damage various organs such as lungs, kidney, heart, skin and joints. Adoption of plasmapheresis removes putative pathogenic autoantibodies and circulates the immune complexes from the blood of patients with systematic lupus erythematosus. Manufacturers in the healthcare industry are increasingly integrating various technological advancements and innovative features in the plasmapheresis instruments such as apheresis machines in order to offer enhanced instruments for conducting plasmapheresis globally. Bound to these factors, the global plasmapheresis market is expected to witness significant growth during the forecast period.
Research for Biopharmaceutical Applications to Impact Global Market Growth
Demand for plasmapheresis also continues to remain high bound to growing need for donation. Growing need for plasma to treat various disorders such as anaemia, stomach disease, blood loss, cancer, burns, childbirth and heart diseases has led to surge in demand for the donation of the blood products. Moreover, blood products donated are also used for the production of biopharmaceutical medications through the process of fractionation. Biopharmaceutical companies are also increasingly investing in the research and development for production of various medications. Surge in demand for biopharmaceutical medications for the treatment of neuroendocrine tumors, diabetes, cancer and arthritis is further expected to fuel demand for plasmapheresis globally. Moreover, growing need for donating blood products and producing biopharmaceutical products has led to an increasing demand for the plasmapheresis in the global market. Such factors will continue to impact growth of the global plasmapheresis market during positively.
Biopharmaceutical Companies to Represent a Leading Segment
Growing need to conduct plasmapheresis has led to surge in demand for various instruments in the global market. On the basis of product type, the instruments segment is expected to represent the highest revenue growth, accounting for a value of over US$ 260 Mn by the end of 2026. However, the disposables product segment is expected to register a robust CAGR during the forecast period.
Based on end users, the biopharmaceutical companies segment is expected to generate significant revenues, recording for a value of over US$ 100 Mn by the end of 2017. In contrary, the other end users segment is expected to register a significant CAGR through 2026.
By application, the source plasma collection segment is expected to witness a robust revenue growth, accounting for a value of nearly US$ 370 Mn by the end of 2026. On the other hand, the centrifugation application segment is expected to register the highest CAGR throughout the forecast period.
Leading market players operating in the global plasmapheresis market include Haemonetics Corporation, Asahi Kasei Kuraray Medical, Terumo Corporation, B Braun Melsungen AG, Baxter Internationalaq IncR4T554RFDD., Fresenius SE & Co. KGaA, Kawasumi Laboratories, Inc. and Kaneka Corporation.
Request research methodology of this report.
Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR
Growing need for biopharmaceutical medicines has led to surge in demand to conduct plasmapheresis. In addition, surge in demand to conduct extracorporeal therapy is further expected to impact growth of the global plasmapheresis market positively. This Fact.MR report analyzes the expansion of global plasmapheresis market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.
The scope of Fact.MR’s report is to analyze the global plasmapheresis market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global plasmapheresis market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to plasmapheresis.
The report commences with a brief information of the global plasmapheresis market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global plasmapheresis market.
The next section offers an overview of the global plasmapheresis market. This comprises an introduction to the market, along with a standard definition of the product – plasmapheresis. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.
The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.
In order to offer readers with up-to-date information about the latest advancements in the global plasmapheresis market, the report provides updates about market opportunities, which can benefit leading manufacturers of plasmapheresis. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for plasmapheresis manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.
The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global plasmapheresis market. Product type, end users, disease, and region are key segments that define the growth of the global market for plasmapheresis. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.
The report’s last section comprises of the global plasmapheresis market competitive landscape, to provide readers with the dashboard view of company analysis and market players. This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global plasmapheresis market.
Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,
- Primary research
- Secondary research
- Trade research
- Focused interviews
- Social media analysis
Fact.MR offers custom research services that help clients to get specific research solutions
We are committed towards customer satisfaction and quality service.